Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome

• Hauptverfasser: Iacopo Fabiani (Verfasst von), Carlo Maria Cipolla (Verfasst von), Nicola Colombo (Verfasst von), Daniela Cardinale (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2020-08-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

BackgroundTreatment with Trastuzumab is associated with cardiotoxicity. If Trastuzumab could be administered in a safe manner to patients who develop a reduced left ventricular ejection fraction (EF) of < 50% remains poorly understood.ObjectiveTo evaluate the impact of a cardioncological approach...